{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T11:07:59Z","timestamp":1786619279489,"version":"build-2736575974"},"reference-count":195,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T00:00:00Z","timestamp":1571788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The liver is the central metabolic organ of mammals. In humans, most diseases of the liver are primarily caused by an unhealthy lifestyle\u2013high fat diet, drug and alcohol consumption- or due to infections and exposure to toxic substances like aflatoxin or other environmental factors. All these noxae cause changes in the metabolism of functional cells in the liver. In this literature review we focus on the changes at the miRNA level, the formation and impact of reactive oxygen species and the crosstalk between those factors. Both, miRNAs and oxidative stress are involved in the multifactorial development and progression of acute and chronic liver diseases, as well as in viral hepatitis and carcinogenesis, by influencing numerous signaling and metabolic pathways. Furthermore, expression patterns of miRNAs and antioxidants can be used for biomonitoring the course of disease and show potential to serve as possible therapeutic targets.<\/jats:p>","DOI":"10.3390\/ijms20215266","type":"journal-article","created":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T03:20:36Z","timestamp":1571973636000},"page":"5266","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["The Crosstalk of miRNA and Oxidative Stress in the Liver: From Physiology to Pathology and Clinical Implications"],"prefix":"10.3390","volume":"20","author":[{"given":"Eckhard","family":"Klieser","sequence":"first","affiliation":[{"name":"Institute of Pathology, Paracelsus Medical University\/Salzburger Landeskliniken (SALK), 5020 Salzburg, Austria"},{"name":"Cancer Cluster Salzburg, 5020 Salzburg, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Mayr","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Paracelsus Medical University\/Salzburger Landeskliniken (SALK), 5020 Salzburg, Austria"},{"name":"Institute of Physiology and Pathophysiology, Paracelsus Medical University\/Salzburger Landeskliniken (SALK), 5020 Salzburg, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Kiesslich","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Paracelsus Medical University\/Salzburger Landeskliniken (SALK), 5020 Salzburg, Austria"},{"name":"Institute of Physiology and Pathophysiology, Paracelsus Medical University\/Salzburger Landeskliniken (SALK), 5020 Salzburg, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Till","family":"Wissniowski","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Endocrinology, Philipps University Marburg, 35043 Marburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0091-8498","authenticated-orcid":false,"given":"Pietro","family":"Di Fazio","sequence":"additional","affiliation":[{"name":"Department of Visceral, Thoracic and Vascular Surgery, Philipps University Marburg, 35043 Marburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Neureiter","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Paracelsus Medical University\/Salzburger Landeskliniken (SALK), 5020 Salzburg, Austria"},{"name":"Cancer Cluster Salzburg, 5020 Salzburg, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8263-6288","authenticated-orcid":false,"given":"Matthias","family":"Ocker","sequence":"additional","affiliation":[{"name":"Translational Medicine Oncology, Bayer AG, 13353 Berlin, Germany"},{"name":"Department of Gastroenterology CBF, Charit\u00e9 University Medicine Berlin, 12200 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,10,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"8082","DOI":"10.3748\/wjg.v20.i25.8082","article-title":"Oxidative stress as a crucial factor in liver diseases","volume":"20","author":"Michalak","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"11715","DOI":"10.1073\/pnas.95.20.11715","article-title":"Mitochondrial reactive oxygen species trigger hypoxia-induced transcription","volume":"95","author":"Chandel","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.molcel.2012.09.025","article-title":"Physiological roles of mitochondrial reactive oxygen species","volume":"48","author":"Sena","year":"2012","journal-title":"Mol. Cell"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"7311","DOI":"10.1128\/MCB.20.19.7311-7318.2000","article-title":"Role for mitochondrial oxidants as regulators of cellular metabolism","volume":"20","author":"Nemoto","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"11727","DOI":"10.1074\/jbc.270.20.11727","article-title":"Involvement of reactive oxygen species in cytokine and growth factor induction of c-fos expression in chondrocytes","volume":"270","author":"Lo","year":"1995","journal-title":"J. Biol. Chem."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1074\/jbc.272.1.217","article-title":"Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation","volume":"272","author":"Bae","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.freeradbiomed.2012.10.532","article-title":"Redox regulation of stem\/progenitor cells and bone marrow niche","volume":"54","author":"Urao","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"The Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group (1994). The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N. Engl. J. Med., 330, 1029\u20131035.","DOI":"10.1056\/NEJM199404143301501"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"120144","DOI":"10.1098\/rsob.120144","article-title":"Oxidants, antioxidants and the current incurability of metastatic cancers","volume":"3","author":"Watson","year":"2013","journal-title":"Open Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1126\/science.1211485","article-title":"Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses","volume":"334","author":"Anastasiou","year":"2011","journal-title":"Science"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1101\/sqb.2012.76.011015","article-title":"Autophagy, stress, and cancer metabolism: What doesn\u2019t kill you makes you stronger","volume":"76","author":"Mathew","year":"2011","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrm3801","article-title":"Cellular mechanisms and physiological consequences of redox-dependent signalling","volume":"15","author":"Holmstrom","year":"2014","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrc1997","article-title":"MicroRNA signatures in human cancers","volume":"6","author":"Calin","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/bjc.2015.253","article-title":"MicroRNAs in cancer: From developmental genes in worms to their clinical application in patients","volume":"113","author":"Pichler","year":"2015","journal-title":"Br. J. Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Kinser, H.E., and Pincus, Z. (2019). MicroRNAs as modulators of longevity and the aging process. Human Genetics, Springer.","DOI":"10.1007\/s00439-019-02046-0"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Greco, S., Gaetano, C., and Martelli, F. (2019). Long Noncoding Competing Endogenous RNA Networks in Age-Associated Cardiovascular Diseases. Int. J. Mol. Sci, 20.","DOI":"10.3390\/ijms20123079"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1055\/s-0034-1397349","article-title":"MicroRNAs in the biology and diagnosis of cholangiocarcinoma","volume":"35","author":"Piontek","year":"2015","journal-title":"Semin. Liver Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1517\/14712598.2015.1025047","article-title":"Histone deacetylation meets miRNA: Epigenetics and post-transcriptional regulation in cancer and chronic diseases","volume":"15","author":"Swierczynski","year":"2015","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1136\/gutjnl-2018-318146","article-title":"miRNAs and NAFLD: From pathophysiology to therapy","volume":"68","author":"Gjorgjieva","year":"2019","journal-title":"Gut"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Collin, F. (2019). Chemical Basis of Reactive Oxygen Species Reactivity and Involvement in Neurodegenerative Diseases. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20102407"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"R100","DOI":"10.1016\/j.cub.2012.12.011","article-title":"Ros","volume":"23","author":"Glasauer","year":"2013","journal-title":"Curr. Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0168-8278(01)00142-8","article-title":"Oxidative stress-related molecules and liver fibrosis","volume":"35","author":"Parola","year":"2001","journal-title":"J. Hepatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.redox.2015.11.006","article-title":"Role of redoximiRs in fibrogenesis","volume":"7","author":"Miguel","year":"2016","journal-title":"Redox Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.cotox.2018.01.002","article-title":"On the history of oxidative stress: Concept and some aspects of current development","volume":"7","author":"Sies","year":"2018","journal-title":"Curr. Opin. Toxicol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1083\/jcb.201102095","article-title":"Signal transduction by reactive oxygen species","volume":"194","author":"Finkel","year":"2011","journal-title":"J. Cell Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nchembio.607","article-title":"Chemistry and biology of reactive oxygen species in signaling or stress responses","volume":"7","author":"Dickinson","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1038\/sj.emboj.7601867","article-title":"Commensal bacteria modulate cullin-dependent signaling via generation of reactive oxygen species","volume":"26","author":"Kumar","year":"2007","journal-title":"EMBO J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1126\/science.1117311","article-title":"A direct role for dual oxidase in Drosophila gut immunity","volume":"310","author":"Ha","year":"2005","journal-title":"Science"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1038\/emboj.2013.224","article-title":"Symbiotic lactobacilli stimulate gut epithelial proliferation via Nox-mediated generation of reactive oxygen species","volume":"32","author":"Jones","year":"2013","journal-title":"EMBO J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"17756","DOI":"10.3748\/wjg.v20.i47.17756","article-title":"Pathogenesis of alcoholic liver disease: Role of oxidative metabolism","volume":"20","author":"Ceni","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"26087","DOI":"10.3390\/ijms161125942","article-title":"The Role of Oxidative Stress and Antioxidants in Liver Diseases","volume":"16","author":"Li","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tibs.2014.02.002","article-title":"The Nrf2 regulatory network provides an interface between redox and intermediary metabolism","volume":"39","author":"Hayes","year":"2014","journal-title":"Trends Biochem. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J. Clin. Investig."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.bpg.2006.07.007","article-title":"Indications of liver transplantation in patients with complications of cirrhosis","volume":"21","author":"Francoz","year":"2007","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0098-2997(00)00004-2","article-title":"Pathogenesis of liver fibrosis: Role of oxidative stress","volume":"21","author":"Poli","year":"2000","journal-title":"Mol. Asp. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00441-016-2445-3","article-title":"Reactive oxygen species and fibrosis: Further evidence of a significant liaison","volume":"365","author":"Richter","year":"2016","journal-title":"Cell Tissue Res."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Meroni, M., Longo, M., Rametta, R., and Dongiovanni, P. (2018). Genetic and Epigenetic Modifiers of Alcoholic Liver Disease. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19123857"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1074\/jbc.M110.145870","article-title":"Up-regulation of microRNA-155 in macrophages contributes to increased tumor necrosis factor \u03b1 (TNF\u03b1) production via increased mRNA half-life in alcoholic liver disease","volume":"286","author":"Bala","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/hep.22470","article-title":"The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88","volume":"48","author":"Hritz","year":"2008","journal-title":"Hepatology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.jhep.2016.01.035","article-title":"The pro-inflammatory effects of miR-155 promote liver fibrosis and alcohol-induced steatohepatitis","volume":"64","author":"Bala","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/hep.29144","article-title":"MicroRNA 181b-3p and its target importin alpha5 regulate toll-like receptor 4 signaling in Kupffer cells and liver injury in mice in response to ethanol","volume":"66","author":"Saikia","year":"2017","journal-title":"Hepatology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"15671","DOI":"10.1038\/s41598-017-15760-4","article-title":"Hyaluronic acid 35 normalizes TLR4 signaling in Kupffer cells from ethanol-fed rats via regulation of microRNA291b and its target Tollip","volume":"7","author":"Saikia","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.molcel.2007.05.017","article-title":"Transcriptional activation of miR-34a contributes to p53-mediated apoptosis","volume":"26","author":"Marciano","year":"2007","journal-title":"Mol. Cell"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"12604","DOI":"10.1074\/jbc.M109.094524","article-title":"A pathway involving farnesoid X receptor and small heterodimer partner positively regulates hepatic sirtuin 1 levels via microRNA-34a inhibition","volume":"285","author":"Lee","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.ajpath.2015.01.030","article-title":"miR-217 regulates ethanol-induced hepatic inflammation by disrupting sirtuin 1-lipin-1 signaling","volume":"185","author":"Yin","year":"2015","journal-title":"Am. J. Pathol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1053\/j.gastro.2017.09.022","article-title":"MicroRNA 122, Regulated by GRLH2, Protects Livers of Mice and Patients from Ethanol-Induced Liver Disease","volume":"154","author":"Satishchandran","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"5491465","DOI":"10.1155\/2016\/5491465","article-title":"Probiotics and Alcoholic Liver Disease: Treatment and Potential Mechanisms","volume":"2016","author":"Li","year":"2016","journal-title":"Gastroenterol. Res. Pract."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1159\/000324281","article-title":"Gut-liver axis and sensing microbes","volume":"28","author":"Szabo","year":"2010","journal-title":"Dig. Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1172\/JCI46039","article-title":"A microRNA-21 surge facilitates rapid cyclin D1 translation and cell cycle progression in mouse liver regeneration","volume":"122","author":"Ng","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"27526","DOI":"10.1074\/jbc.M114.602383","article-title":"Regulation of the extrinsic apoptotic pathway by microRNA-21 in alcoholic liver injury","volume":"289","author":"Francis","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/jcp.26938","article-title":"MicroRNAs in alcoholic liver disease: Recent advances and future applications","volume":"234","author":"Xu","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"5232","DOI":"10.4049\/jimmunol.0901084","article-title":"Ethanol-induced expression of ET-1 and ET-BR in liver sinusoidal endothelial cells and human endothelial cells involves hypoxia-inducible factor-1alpha and microrNA-199","volume":"183","author":"Yeligar","year":"2009","journal-title":"J. Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/acer.12209","article-title":"MiR-214 promotes the alcohol-induced oxidative stress via down-regulation of glutathione reductase and cytochrome P450 oxidoreductase in liver cells","volume":"38","author":"Dong","year":"2014","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.bcp.2017.04.020","article-title":"A systematic evaluation of microRNAs in regulating human hepatic CYP2E1","volume":"138","author":"Wang","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/liv.13643","article-title":"Global epidemiology of non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis: What we need in the future","volume":"38","author":"Araujo","year":"2018","journal-title":"Liver Int."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/hep.22399","article-title":"Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis","volume":"48","author":"Maher","year":"2008","journal-title":"Hepatology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/stem.2454","article-title":"Concise Review: Current Status and Future Directions on Research Related to Nonalcoholic Fatty Liver Disease","volume":"35","author":"Wruck","year":"2017","journal-title":"Stem Cells"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cld.2017.08.007","article-title":"Pathophysiology of Nonalcoholic Fatty Liver Disease\/Nonalcoholic Steatohepatitis","volume":"22","author":"Manne","year":"2018","journal-title":"Clin. Liver Dis."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"5170402","DOI":"10.1155\/2016\/5170402","article-title":"Pathogenesis of Nonalcoholic Steatohepatitis: Interactions between Liver Parenchymal and Nonparenchymal Cells","volume":"2016","author":"Magee","year":"2016","journal-title":"Biomed. Res. Int."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/hep.26226","article-title":"Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease","volume":"58","author":"Begriche","year":"2013","journal-title":"Hepatology"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.cellsig.2011.05.008","article-title":"Mitochondrial stress: A bridge between mitochondrial dysfunction and metabolic diseases?","volume":"23","author":"Hu","year":"2011","journal-title":"Cell. Signal."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cmet.2015.04.004","article-title":"Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis","volume":"21","author":"Koliaki","year":"2015","journal-title":"Cell Metab."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.3109\/10715762.2015.1078461","article-title":"Endoplasmic reticulum stress and Oxidative stress in the pathogenesis of Non-alcoholic fatty liver disease","volume":"49","author":"Ashraf","year":"2015","journal-title":"Free Radic. Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1101\/gad.13.10.1211","article-title":"Stress signaling from the lumen of the endoplasmic reticulum: Coordination of gene transcriptional and translational controls","volume":"13","author":"Kaufman","year":"1999","journal-title":"Genes Dev."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Miyamoto, Y., Mauer, A.S., Kumar, S., Mott, J.L., and Malhi, H. (2014). Mmu-miR-615-3p regulates lipoapoptosis by inhibiting C\/EBP homologous protein. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0109637"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"19320","DOI":"10.1073\/pnas.1012044107","article-title":"Sarco(endo)plasmic reticulum Ca2+-ATPase 2b is a major regulator of endoplasmic reticulum stress and glucose homeostasis in obesity","volume":"107","author":"Park","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"C279","DOI":"10.1152\/ajpcell.00117.2013","article-title":"Enhanced endoplasmic reticulum SERCA activity by overexpression of hepatic stimulator substance gene prevents hepatic cells from ER stress-induced apoptosis","volume":"306","author":"Zhang","year":"2014","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.freeradbiomed.2009.11.007","article-title":"Loss of Nrf2 markedly exacerbates nonalcoholic steatohepatitis","volume":"48","author":"Chowdhry","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"G283","DOI":"10.1152\/ajpgi.00296.2009","article-title":"Deletion of nuclear factor-E2-related factor-2 leads to rapid onset and progression of nutritional steatohepatitis in mice","volume":"298","author":"Sugimoto","year":"2010","journal-title":"Am. J. Physiol. Gastrointest Liver Physiol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/hep.21093","article-title":"Phagocytosis of apoptotic bodies by hepatic stellate cells induces NADPH oxidase and is associated with liver fibrosis in vivo","volume":"43","author":"Zhan","year":"2006","journal-title":"Hepatology"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.4254\/wjh.v7.i24.2497","article-title":"Epigenetic mechanisms in non-alcoholic fatty liver disease: An emerging field","volume":"7","year":"2015","journal-title":"World J. Hepatol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"G298","DOI":"10.1152\/ajpgi.00346.2014","article-title":"Micro-RNA 21 inhibition of SMAD7 enhances fibrogenesis via leptin-mediated NADPH oxidase in experimental and human nonalcoholic steatohepatitis","volume":"308","author":"Dattaroy","year":"2015","journal-title":"Am. J. Physiol. Gastrointest Liver Physiol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1002\/hep.22737","article-title":"Unsaturated fatty acids inhibit the expression of tumor suppressor phosphatase and tensin homolog (PTEN) via microRNA-21 up-regulation in hepatocytes","volume":"49","author":"Vinciguerra","year":"2009","journal-title":"Hepatology"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"e2748","DOI":"10.1038\/cddis.2017.172","article-title":"miR-21 ablation and obeticholic acid ameliorate nonalcoholic steatohepatitis in mice","volume":"8","author":"Rodrigues","year":"2017","journal-title":"Cell Death Dis."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1136\/gutjnl-2014-308883","article-title":"Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARalpha expression","volume":"65","author":"Loyer","year":"2016","journal-title":"Gut"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3389\/fphys.2019.00279","article-title":"Regulatory Non-coding RNAs Network in Non-alcoholic Fatty Liver Disease","volume":"10","author":"Sulaiman","year":"2019","journal-title":"Front. Physiol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/ijpo.12261","article-title":"Circulating levels of miR-122 and nonalcoholic fatty liver disease in pre-pubertal obese children","volume":"13","author":"Brandt","year":"2018","journal-title":"Pediatr. Obes."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/ijo.2017.21","article-title":"Decreased lipid metabolism but increased FA biosynthesis are coupled with changes in liver microRNAs in obese subjects with NAFLD","volume":"41","author":"Latorre","year":"2017","journal-title":"Int. J. Obes. (Lond.)"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.addr.2018.01.009","article-title":"MicroRNAs in the pathogenesis and treatment of progressive liver injury in NAFLD and liver fibrosis","volume":"129","author":"Su","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Cermelli, S., Ruggieri, A., Marrero, J.A., Ioannou, G.N., and Beretta, L. (2011). Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0023937"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"e302","DOI":"10.1111\/liv.12429","article-title":"Significance of serum and hepatic microRNA-122 levels in patients with non-alcoholic fatty liver disease","volume":"34","author":"Miyaaki","year":"2014","journal-title":"Liver Int."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s00109-017-1586-5","article-title":"NEAT1 accelerates the progression of liver fibrosis via regulation of microRNA-122 and Kruppel-like factor 6","volume":"95","author":"Yu","year":"2017","journal-title":"J. Mol. Med. (Berl.)"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1172\/JCI63539","article-title":"Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver","volume":"122","author":"Hsu","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Salvoza, N.C., Klinzing, D.C., Gopez-Cervantes, J., and Baclig, M.O. (2016). Association of Circulating Serum miR-34a and miR-122 with Dyslipidemia among Patients with Non-Alcoholic Fatty Liver Disease. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0153497"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cca.2013.05.021","article-title":"Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver","volume":"424","author":"Yamada","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.molcel.2007.05.010","article-title":"Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis","volume":"26","author":"Chang","year":"2007","journal-title":"Mol. Cell"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"13729","DOI":"10.1038\/srep13729","article-title":"Effect of miR-34a in regulating steatosis by targeting PPARalpha expression in nonalcoholic fatty liver disease","volume":"5","author":"Ding","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e1833","DOI":"10.1038\/cddis.2015.196","article-title":"Activation of the SIRT1\/p66shc antiapoptosis pathway via carnosic acid-induced inhibition of miR-34a protects rats against nonalcoholic fatty liver disease","volume":"6","author":"Shan","year":"2015","journal-title":"Cell Death Dis."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"7466","DOI":"10.1038\/ncomms8466","article-title":"A metabolic stress-inducible miR-34a-HNF4alpha pathway regulates lipid and lipoprotein metabolism","volume":"6","author":"Xu","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jhep.2012.08.008","article-title":"miR-34a\/SIRT1\/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease","volume":"58","author":"Castro","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jhep.2012.11.042","article-title":"Inhibition of p53 attenuates steatosis and liver injury in a mouse model of non-alcoholic fatty liver disease","volume":"58","author":"Derdak","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/liv.13097","article-title":"Deregulated hepatic microRNAs underlie the association between non-alcoholic fatty liver disease and coronary artery disease","volume":"36","author":"Molina","year":"2016","journal-title":"Liver Int."},{"key":"ref_93","first-page":"24","article-title":"The role of miRNAs in the regulation of inflammatory processes during hepatofibrogenesis","volume":"4","author":"Roy","year":"2015","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/aps.2016.158","article-title":"Dicer1\/miR-29\/HMGCR axis contributes to hepatic free cholesterol accumulation in mouse non-alcoholic steatohepatitis","volume":"38","author":"Liu","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/hep.27379","article-title":"A screen in mice uncovers repression of lipoprotein lipase by microRNA-29a as a mechanism for lipid distribution away from the liver","volume":"61","author":"Mattis","year":"2015","journal-title":"Hepatology"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"12911","DOI":"10.1038\/srep12911","article-title":"Inhibition of miR-29 has a significant lipid-lowering benefit through suppression of lipogenic programs in liver","volume":"5","author":"Kurtz","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1093\/infdis\/jir186","article-title":"Hepatitis C virus infection and hepatic stellate cell activation downregulate miR-29: miR-29 overexpression reduces hepatitis C viral abundance in culture","volume":"203","author":"Bandyopadhyay","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/labinvest.2010.113","article-title":"Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice","volume":"90","author":"Pogribny","year":"2010","journal-title":"Lab. Investig."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1159\/000495556","article-title":"Thymosin-beta4 Mediates Hepatic Stellate Cell Activation by Interfering with CircRNA-0067835\/miR-155\/FoxO3 Signaling Pathway","volume":"51","author":"Zhu","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1159\/000447917","article-title":"Decreased MiR-155 Level in the Peripheral Blood of Non-Alcoholic Fatty Liver Disease Patients may Serve as a Biomarker and may Influence LXR Activity","volume":"39","author":"Wang","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/liv.12633","article-title":"microRNA-122 regulates hypoxia-inducible factor-1 and vimentin in hepatocytes and correlates with fibrosis in diet-induced steatohepatitis","volume":"35","author":"Csak","year":"2015","journal-title":"Liver Int."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Csak, T., Bala, S., Lippai, D., Kodys, K., Catalano, D., Iracheta-Vellve, A., and Szabo, G. (2015). MicroRNA-155 Deficiency Attenuates Liver Steatosis and Fibrosis without Reducing Inflammation in a Mouse Model of Steatohepatitis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0129251"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Okamoto, K., Koda, M., Okamoto, T., Onoyama, T., Miyoshi, K., Kishina, M., Kato, J., Tokunaga, S., Sugihara, T.A., and Hara, Y. (2016). A Series of microRNA in the Chromosome 14q32.2 Maternally Imprinted Region Related to Progression of Non-Alcoholic Fatty Liver Disease in a Mouse Model. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0154676"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1083\/jcb.201010055","article-title":"A CHOP-regulated microRNA controls rhodopsin expression","volume":"192","author":"Behrman","year":"2011","journal-title":"J. Cell Biol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.molcel.2012.08.025","article-title":"miR-211 is a prosurvival microRNA that regulates chop expression in a PERK-dependent manner","volume":"48","author":"Chitnis","year":"2012","journal-title":"Mol. Cell"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.gene.2013.09.005","article-title":"Mmu-miR-702 functions as an anti-apoptotic mirtron by mediating ATF6 inhibition in mice","volume":"531","author":"Zhang","year":"2013","journal-title":"Gene"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.yjmcc.2012.01.017","article-title":"Regulation of microRNA expression in the heart by the ATF6 branch of the ER stress response","volume":"52","author":"Belmont","year":"2012","journal-title":"J. Mol. Cell Cardiol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s40139-014-0046-y","article-title":"Micrornas in er stress: Divergent roles in cell fate decisions","volume":"2","author":"Malhi","year":"2014","journal-title":"Curr. Pathobiol. Rep."},{"key":"ref_109","unstructured":"WHO (2019, September 29). Hepatitis C. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c."},{"key":"ref_110","unstructured":"WHO (2019, September 29). Hepatitis B. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"G847","DOI":"10.1152\/ajpgi.00522.2005","article-title":"Mechanisms of liver injury. III. Oxidative stress in the pathogenesis of hepatitis C virus","volume":"290","author":"Choi","year":"2006","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s12072-009-9158-6","article-title":"Role of free radicals in liver diseases","volume":"3","author":"Muriel","year":"2009","journal-title":"Hepatol. Int."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0168-8278(95)80108-1","article-title":"Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis","volume":"22","author":"Farinati","year":"1995","journal-title":"J. Hepatol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/hep.23401","article-title":"MicroRNA-196 represses Bach1 protein and hepatitis C virus gene expression in human hepatoma cells expressing hepatitis C viral proteins","volume":"51","author":"Hou","year":"2010","journal-title":"Hepatology"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1126\/science.1113329","article-title":"Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA","volume":"309","author":"Jopling","year":"2005","journal-title":"Science"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev-virology-110615-042409","article-title":"Unraveling the Mysterious Interactions Between Hepatitis C Virus RNA and Liver-Specific MicroRNA-122","volume":"3","author":"Sarnow","year":"2016","journal-title":"Annu. Rev. Virol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"e01617-19","DOI":"10.1128\/mBio.01617-19","article-title":"Hepatitis C Virus Infection Induces Hepatic Expression of NF-kappaB-Inducing Kinase and Lipogenesis by Downregulating miR-122","volume":"10","author":"Lowey","year":"2019","journal-title":"MBio"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"e12743","DOI":"10.1111\/acel.12743","article-title":"NHR-49\/HNF4 integrates regulation of fatty acid metabolism with a protective transcriptional response to oxidative stress and fasting","volume":"17","author":"Goh","year":"2018","journal-title":"Aging Cell"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nm.3190","article-title":"Hepatitis C virus infection activates an innate pathway involving IKK-alpha in lipogenesis and viral assembly","volume":"19","author":"Li","year":"2013","journal-title":"Nat. Med."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/hep.24809","article-title":"Loss of microRNA 122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G(1) -modulated P53 activity","volume":"55","author":"Wang","year":"2012","journal-title":"Hepatology"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"527","DOI":"10.18388\/abp.2016_1216","article-title":"Hepatic expression of miR-122 and antioxidant genes in patients with chronic hepatitis B","volume":"63","author":"Wojcik","year":"2016","journal-title":"Acta Biochim. Pol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/hep.22158","article-title":"MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma","volume":"47","author":"Varnholt","year":"2008","journal-title":"Hepatology"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s40471-019-00188-3","article-title":"The changing epidemiology of primary liver cancer","volume":"6","author":"Petrick","year":"2019","journal-title":"Curr. Epidemiol. Rep."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: Current concepts and future challenges","volume":"16","author":"Anstee","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.3748\/wjg.v25.i25.3136","article-title":"Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targets","volume":"25","author":"Neureiter","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"4968321","DOI":"10.1155\/2018\/4968321","article-title":"From Oxidative Stress Damage to Pathways, Networks, and Autophagy via MicroRNAs","volume":"2018","author":"Engedal","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1053\/j.gastro.2018.06.083","article-title":"Mitochondrial Dysfunction and Signaling in Chronic Liver Diseases","volume":"155","author":"Mansouri","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"9547613","DOI":"10.1155\/2018\/9547613","article-title":"Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease","volume":"2018","author":"Masarone","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.3892\/ol.2017.6296","article-title":"Hepatitis B virus X protein promotes hepatocellular carcinoma invasion and metastasis via upregulating thioredoxin interacting protein","volume":"14","author":"He","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3390\/v5020439","article-title":"HCV and oxidative stress in the liver","volume":"5","author":"Ivanov","year":"2013","journal-title":"Viruses"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"9012580","DOI":"10.1155\/2016\/9012580","article-title":"HCV and Oxidative Stress: Implications for HCV Life Cycle and HCV-Associated Pathogenesis","volume":"2016","author":"Medvedev","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.cbi.2007.03.006","article-title":"HBx or HCV core gene expression in HepG2 human liver cells results in a survival benefit against oxidative stress with possible implications for HCC development","volume":"168","author":"Severi","year":"2007","journal-title":"Chem. Biol. Interact."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"e00001-17","DOI":"10.1128\/JVI.00001-17","article-title":"Reactive Oxygen Species-Mediated c-Jun NH2-Terminal Kinase Activation Contributes to Hepatitis B Virus X Protein-Induced Autophagy via Regulation of the Beclin-1\/Bcl-2 Interaction","volume":"91","author":"Zhong","year":"2017","journal-title":"J. Virol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/1479-5876-9-171","article-title":"Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: An overview","volume":"9","author":"Marra","year":"2011","journal-title":"J. Transl. Med."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/sj.bjc.6604204","article-title":"Hepatic oxidative DNA damage is associated with increased risk for hepatocellular carcinoma in chronic hepatitis C","volume":"98","author":"Tanaka","year":"2008","journal-title":"Br. J. Cancer"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3892\/ol.2011.477","article-title":"8-Hydroxy-2\u2019-deoxyguanosine expression predicts hepatocellular carcinoma outcome","volume":"3","author":"Li","year":"2012","journal-title":"Oncol. Lett."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.cellsig.2016.05.021","article-title":"OGG1 is essential in oxidative stress induced DNA demethylation","volume":"28","author":"Zhou","year":"2016","journal-title":"Cell. Signal."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.2741\/4668","article-title":"The biological and diagnostic role of miRNA\u2019s in hepatocellular carcinoma","volume":"23","author":"Sartorius","year":"2018","journal-title":"Front. Biosci."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1056\/NEJMoa0901282","article-title":"MicroRNA expression, survival, and response to interferon in liver cancer","volume":"361","author":"Ji","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrgastro.2017.169","article-title":"Non-coding RNAs in hepatocellular carcinoma: Molecular functions and pathological implications","volume":"15","author":"Wong","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"6069","DOI":"10.1158\/0008-5472.CAN-16-2964","article-title":"TET-Mediated Sequestration of miR-26 Drives EZH2 Expression and Gastric Carcinogenesis","volume":"77","author":"Deng","year":"2017","journal-title":"Cancer Res."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1158\/0008-5472.CAN-10-1850","article-title":"MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2","volume":"71","author":"Lu","year":"2011","journal-title":"Cancer Res."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s12032-014-0437-2","article-title":"Erratum to: Negative feedback of miR-29 family TET1 involves in hepatocellular cancer","volume":"32","author":"Lin","year":"2015","journal-title":"Med. Oncol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/hep.27816","article-title":"MicroRNA-494 is a master epigenetic regulator of multiple invasion-suppressor microRNAs by targeting ten eleven translocation 1 in invasive human hepatocellular carcinoma tumors","volume":"62","author":"Chuang","year":"2015","journal-title":"Hepatology"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.bbrc.2015.03.108","article-title":"MiR-520b suppresses proliferation of hepatoma cells through targeting ten-eleven translocation 1 (TET1) mRNA","volume":"460","author":"Zhang","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_147","unstructured":"Cardin, R., Piciocchi, M., Sinigaglia, A., Lavezzo, E., Bortolami, M., Kotsafti, A., Cillo, U., Zanus, G., Mescoli, C., and Rugge, M. (2012). Oxidative DNA damage correlates with cell immortalization and mir-92 expression in hepatocellular carcinoma. BMC Cancer, 12."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/mc.22122","article-title":"The pan-deacetylase inhibitor panobinostat suppresses the expression of oncogenic miRNAs in hepatocellular carcinoma cell lines","volume":"54","author":"Henrici","year":"2015","journal-title":"Mol. Carcinog."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.brainres.2010.05.059","article-title":"Profiles of oxidative stress-related microRNA and mRNA expression in auditory cells","volume":"1346","author":"Wang","year":"2010","journal-title":"Brain Res."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.3748\/wjg.v11.i29.4587","article-title":"Expression and hypermethylation of p27 kip1 in hepatocarcinogenesis","volume":"11","author":"Lei","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/j.yexcr.2012.04.018","article-title":"Downregulation of HMGA2 by the pan-deacetylase inhibitor panobinostat is dependent on hsa-let-7b expression in liver cancer cell lines","volume":"318","author":"Montalbano","year":"2012","journal-title":"Exp. Cell Res."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1080\/10715762.2017.1291942","article-title":"Oxidative stress and inflammation: Liver responses and adaptations to acute and regular exercise","volume":"51","author":"Bresciani","year":"2017","journal-title":"Free Radic. Res."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.gastrohep.2012.03.004","article-title":"Antioxidant supplementation attenuates oxidative stress in chronic hepatitis C patients","volume":"35","author":"Farias","year":"2012","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.omtn.2017.06.005","article-title":"Therapeutic miRNA and siRNA: Moving from Bench to Clinic as Next Generation Medicine","volume":"8","author":"Chakraborty","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/apha.12681","article-title":"MicroRNAs in metabolism","volume":"219","author":"Vienberg","year":"2017","journal-title":"Acta Physiol. (Oxf.)"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/nature06783","article-title":"LNA-mediated microRNA silencing in non-human primates","volume":"452","author":"Elmen","year":"2008","journal-title":"Nature"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1158\/0008-5472.CAN-08-2749","article-title":"MicroRNA silencing in primates: Towards development of novel therapeutics","volume":"69","author":"Petri","year":"2009","journal-title":"Cancer Res."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.omtn.2016.12.003","article-title":"Preclinical and Clinical Advances of GalNAc-Decorated Nucleic Acid Therapeutics","volume":"6","author":"Huang","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.molmed.2010.03.004","article-title":"MiR-210--micromanager of the hypoxia pathway","volume":"16","author":"Huang","year":"2010","journal-title":"Trends Mol. Med."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1074\/jbc.M110.170852","article-title":"MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1)","volume":"286","author":"Tsuchiya","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/cdd.2010.119","article-title":"miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity","volume":"18","author":"Puissegur","year":"2011","journal-title":"Cell Death Differ."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/iub.427","article-title":"miR-210: More than a silent player in hypoxia","volume":"63","author":"Devlin","year":"2011","journal-title":"IUBMB Life"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.molcel.2009.09.006","article-title":"Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation","volume":"35","author":"Huang","year":"2009","journal-title":"Mol. Cell"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12967-015-0623-9","article-title":"Increased number of circulating exosomes and their microRNA cargos are potential novel biomarkers in alcoholic hepatitis","volume":"13","author":"Saha","year":"2015","journal-title":"J. Transl. Med."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nature10112","article-title":"MicroRNAs 103 and 107 regulate insulin sensitivity","volume":"474","author":"Trajkovski","year":"2011","journal-title":"Nature"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1002\/hep.25873","article-title":"Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases","volume":"56","author":"Bala","year":"2012","journal-title":"Hepatology"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa1209026","article-title":"Treatment of HCV infection by targeting microRNA","volume":"368","author":"Janssen","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/nar\/gkt852","article-title":"Miravirsen (SPC3649) can inhibit the biogenesis of miR-122","volume":"42","author":"Gebert","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.3748\/wjg.v21.i14.4103","article-title":"Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: An open question","volume":"21","author":"Streba","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver, and European Association for the Study of Diabetes (2016). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J. Hepatol., 64, 1388\u20131402.","DOI":"10.1016\/j.jhep.2015.11.004"},{"key":"ref_171","first-page":"161","article-title":"The Role of MicroRNAs in Human Diseases","volume":"2","author":"Ardekani","year":"2010","journal-title":"Avicenna J. Med. Biotechnol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/bcpt.13122","article-title":"Protective effect of isochlorogenic acid B on liver fibrosis in non-alcoholic steatohepatitis of mice","volume":"124","author":"Liu","year":"2019","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.biomaterials.2015.10.047","article-title":"Co-delivery of small molecule hedgehog inhibitor and miRNA for treating liver fibrosis","volume":"76","author":"Kumar","year":"2016","journal-title":"Biomaterials"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1002\/art.27443","article-title":"MicroRNA-29, a key regulator of collagen expression in systemic sclerosis","volume":"62","author":"Maurer","year":"2010","journal-title":"Arthritis Rheum."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/cas.12730","article-title":"Inhibition of microRNA-214 ameliorates hepatic fibrosis and tumor incidence in platelet-derived growth factor C transgenic mice","volume":"106","author":"Okada","year":"2015","journal-title":"Cancer Sci."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1111\/liv.14067","article-title":"MicroRNA-30b regulates insulin sensitivity by targeting SERCA2b in non-alcoholic fatty liver disease","volume":"39","author":"Dai","year":"2019","journal-title":"Liver Int."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"9551","DOI":"10.18632\/oncotarget.3314","article-title":"Serum thioredoxin is a diagnostic marker for hepatocellular carcinoma","volume":"6","author":"Li","year":"2015","journal-title":"Oncotarget"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/039463201402700204","article-title":"Expression of thioredoxins and glutaredoxins in human hepatocellular carcinoma: Correlation to cell proliferation, tumor size and metabolic syndrome","volume":"27","author":"Mollbrink","year":"2014","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.3748\/wjg.v17.i44.4890","article-title":"Serum manganese superoxide dismutase and thioredoxin are potential prognostic markers for hepatitis C virus-related hepatocellular carcinoma","volume":"17","author":"Tamai","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.3390\/ijerph10093886","article-title":"Pulmonary oxidative stress, inflammation and cancer: Respirable particulate matter, fibrous dusts and ozone as major causes of lung carcinogenesis through reactive oxygen species mechanisms","volume":"10","author":"Valavanidis","year":"2013","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/j.1440-1746.2008.05502.x","article-title":"8-Hydroxy-2\u2019-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection","volume":"23","author":"Chuma","year":"2008","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1034\/j.1478-3231.2003.00868.x","article-title":"Expression of 8-hydroxy-2\u2019-deoxyguanosine in chronic liver disease and hepatocellular carcinoma","volume":"23","author":"Ichiba","year":"2003","journal-title":"Liver Int."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s12032-017-0914-5","article-title":"Oxidative stress indicated by elevated expression of Nrf2 and 8-OHdG promotes hepatocellular carcinoma progression","volume":"34","author":"Sanpavat","year":"2017","journal-title":"Med. Oncol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s00535-012-0739-0","article-title":"Increased hepatic oxidative DNA damage in patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma","volume":"48","author":"Tanaka","year":"2013","journal-title":"J. Gastroenterol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4161\/rna.18827","article-title":"Liver-specific microRNA-122: Biogenesis and function","volume":"9","author":"Jopling","year":"2012","journal-title":"RNA Biol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1038\/sj.onc.1210008","article-title":"Role of hypoxia inducible factor-1 alpha in modulation of apoptosis resistance","volume":"26","author":"Kilic","year":"2007","journal-title":"Oncogene"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1039\/C8BM00639C","article-title":"Simple and rational design of a polymer nano-platform for high performance of HCV related miR-122 reduction in the liver","volume":"6","author":"Fu","year":"2018","journal-title":"Biomater Sci."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"4698167","DOI":"10.1155\/2017\/4698167","article-title":"TXNRD1 Is an Unfavorable Prognostic Factor for Patients with Hepatocellular Carcinoma","volume":"2017","author":"Fu","year":"2017","journal-title":"Biomed. Res. Int."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/hep.30467","article-title":"Induction of Oxidative Stress Through Inhibition of Thioredoxin Reductase 1 Is an Effective Therapeutic Approach for Hepatocellular Carcinoma","volume":"69","author":"Lee","year":"2019","journal-title":"Hepatology"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"11851","DOI":"10.1158\/0008-5472.CAN-06-1377","article-title":"Sorafenib blocks the RAF\/MEK\/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC\/PRF\/5","volume":"66","author":"Liu","year":"2006","journal-title":"Cancer Res."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1158\/0008-5472.CAN-04-1443","article-title":"BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF\/MEK\/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis","volume":"64","author":"Wilhelm","year":"2004","journal-title":"Cancer Res."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1158\/1535-7163.MCT-12-0093","article-title":"Sorafenib-induced hepatocellular carcinoma cell death depends on reactive oxygen species production in vitro and in vivo","volume":"11","author":"Coriat","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.tox.2018.01.005","article-title":"Mechanisms of mitochondrial toxicity of the kinase inhibitors ponatinib, regorafenib and sorafenib in human hepatic HepG2 cells","volume":"395","author":"Paech","year":"2018","journal-title":"Toxicology"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1021\/pr200790e","article-title":"Sorafenib-induced mitochondrial complex I inactivation and cell death in human neuroblastoma cells","volume":"11","author":"Bull","year":"2012","journal-title":"J. Proteome Res."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"11448","DOI":"10.1038\/s41598-017-11943-1","article-title":"MicroRNA pharmacogenomics based integrated model of miR-17-92 cluster in sorafenib resistant HCC cells reveals a strategy to forestall drug resistance","volume":"7","author":"Awan","year":"2017","journal-title":"Sci. Rep."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/21\/5266\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:28:47Z","timestamp":1760189327000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/21\/5266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,23]]},"references-count":195,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2019,11]]}},"alternative-id":["ijms20215266"],"URL":"https:\/\/doi.org\/10.3390\/ijms20215266","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,23]]}}}